Holger Eidtmann

24.1k citations
128 papers · 9.1k · 2 hit papers · h-index 42

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.2%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Bone health and treatments
    • Cancer Cells and Metastasis

Papers in

    • Cancer Treatment and Pharmacology 40
    • HER2/EGFR in Cancer Research 37
    • Bone health and treatments 9
    • Breast Cancer Treatment Studies 65

Holger Eidtmann

123 papers receiving 8.8k citations

Holger Eidtmann's Hit Papers

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab 2015 · 445 citations
4450+4+9Years since publication50010001.5k

Peers

Holger Eidtmann
Comparison fields: 5 of 96
  • Cancer Research 4.3k
  • Oncology 5.0k
  • Radiology, Nuclear Medicine and Imaging 1.1k
  • Pathology and Forensic Medicine 795
  • Pulmonary and Respiratory Medicine 1000
Replace Serban Dan Costa with:
Serban Dan Costa Germany
M. Tubiana-Hulin France
Lina Asmar United States
Dimosthenis Skarlos Greece
Arlene Chan Australia
J. Thaddeus Beck United States
Roberto Hegg Brazil
Gaia Schiavon United Kingdom
Milvia Zambetti Italy
Antonio Frassoldati Italy
Holger Eidtmann relative to Serban Dan Costa Germany Serban Dan Costa's profile →
Citations per field
00.5×1.7×
Serban Dan Costa · 1×
Citations per year

Countries citing papers authored by Holger Eidtmann

Since Specialization
Citations

This map shows the geographic impact of Holger Eidtmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Eidtmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Eidtmann more than expected).

Fields of papers citing papers by Holger Eidtmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Eidtmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Eidtmann. The network helps show where Holger Eidtmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Holger Eidtmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Holger Eidtmann Line = papers co-authored together Holger Eidtmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Hit paper breakdown →
20121905
2
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab
Hit paper breakdown →
2015445
3 2010422
4 2010418
5 2011355
6 2005327
7 2012314
8 2013274
9 2012266
10 2010241
11 2008217
12 2007206
13 1993189
14 2008185
15 2008179
16 2013178
17 2010161
18 2004151
19 2001119
20 2012119

About Holger Eidtmann

Holger Eidtmann is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 128 papers that have together received 9.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (65 papers), Cancer Treatment and Pharmacology (40 papers), HER2/EGFR in Cancer Research (37 papers), Advanced Breast Cancer Therapies (29 papers), Breast Lesions and Carcinomas (12 papers), Estrogen and related hormone effects (11 papers), Bone health and treatments (9 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Cancer Research (4.3k citations), Oncology (5.0k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations), Pathology and Forensic Medicine (795 citations) and Pulmonary and Respiratory Medicine (1000 citations). Holger Eidtmann has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Gϋnter von Minckwitz, J. Hilfrich, Christian Jackisch, Sibylle Loibl, Jens‐Uwe Blohmer, Jens Huober, Serban Dan Costa, Manfred Kaufmann, Michael Untch and Bernd Gerber. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, European Journal of Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact